This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.


Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


1alu

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
(New page: 200px<br /> <applet load="1alu" size="450" color="white" frame="true" align="right" spinBox="true" caption="1alu, resolution 1.9&Aring;" /> '''HUMAN INTERLEUKIN-6'...)
Line 1: Line 1:
-
[[Image:1alu.gif|left|200px]]<br />
+
[[Image:1alu.gif|left|200px]]<br /><applet load="1alu" size="350" color="white" frame="true" align="right" spinBox="true"
-
<applet load="1alu" size="450" color="white" frame="true" align="right" spinBox="true"
+
caption="1alu, resolution 1.9&Aring;" />
caption="1alu, resolution 1.9&Aring;" />
'''HUMAN INTERLEUKIN-6'''<br />
'''HUMAN INTERLEUKIN-6'''<br />
==Overview==
==Overview==
-
Interleukin 6 (IL-6) has many biological activities in vivo, and, deregulation has been implicated in many disease processes. IL-6, a 185, amino acid polypeptide was refolded, purified and crystallized. The, crystals diffracted to beyond 1.9 A and the structure was solved using, single isomorphous replacement. The X-ray structure of IL-6 is composed of, a four helix bundle linked by loops and an additional mini-helix. 157 out, of 185 residues are well defined in the final structure, with 18, N-terminal and 8 A-B loop amino acids displaying no interpretable electron, density. The three-dimensional structure has been used to construct a, model of IL-6 interacting with the IL-6 receptor (alpha-chain) and gp130, (beta-chain) that gives new insight into the process of molecular, recognition and signaling. Based on this model, we predict a fourth, binding site on IL-6, a low affinity IL-6-IL-6 interaction, which may be, necessary for the sequential assembly of a functional hexameric IL-6, receptor complex.
+
Interleukin 6 (IL-6) has many biological activities in vivo, and deregulation has been implicated in many disease processes. IL-6, a 185 amino acid polypeptide was refolded, purified and crystallized. The crystals diffracted to beyond 1.9 A and the structure was solved using single isomorphous replacement. The X-ray structure of IL-6 is composed of a four helix bundle linked by loops and an additional mini-helix. 157 out of 185 residues are well defined in the final structure, with 18 N-terminal and 8 A-B loop amino acids displaying no interpretable electron density. The three-dimensional structure has been used to construct a model of IL-6 interacting with the IL-6 receptor (alpha-chain) and gp130 (beta-chain) that gives new insight into the process of molecular recognition and signaling. Based on this model, we predict a fourth binding site on IL-6, a low affinity IL-6-IL-6 interaction, which may be necessary for the sequential assembly of a functional hexameric IL-6 receptor complex.
==Disease==
==Disease==
Line 11: Line 10:
==About this Structure==
==About this Structure==
-
1ALU is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with SO4 and TLA as [http://en.wikipedia.org/wiki/ligands ligands]. Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=1ALU OCA].
+
1ALU is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with <scene name='pdbligand=SO4:'>SO4</scene> and <scene name='pdbligand=TLA:'>TLA</scene> as [http://en.wikipedia.org/wiki/ligands ligands]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1ALU OCA].
==Reference==
==Reference==
Line 17: Line 16:
[[Category: Homo sapiens]]
[[Category: Homo sapiens]]
[[Category: Single protein]]
[[Category: Single protein]]
-
[[Category: Seehra, J.S.]]
+
[[Category: Seehra, J S.]]
-
[[Category: Somers, W.S.]]
+
[[Category: Somers, W S.]]
[[Category: Stahl, M.]]
[[Category: Stahl, M.]]
[[Category: SO4]]
[[Category: SO4]]
Line 28: Line 27:
[[Category: signaling]]
[[Category: signaling]]
-
''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Mon Nov 12 15:59:38 2007''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 11:45:56 2008''

Revision as of 09:45, 21 February 2008


1alu, resolution 1.9Å

Drag the structure with the mouse to rotate

HUMAN INTERLEUKIN-6

Contents

Overview

Interleukin 6 (IL-6) has many biological activities in vivo, and deregulation has been implicated in many disease processes. IL-6, a 185 amino acid polypeptide was refolded, purified and crystallized. The crystals diffracted to beyond 1.9 A and the structure was solved using single isomorphous replacement. The X-ray structure of IL-6 is composed of a four helix bundle linked by loops and an additional mini-helix. 157 out of 185 residues are well defined in the final structure, with 18 N-terminal and 8 A-B loop amino acids displaying no interpretable electron density. The three-dimensional structure has been used to construct a model of IL-6 interacting with the IL-6 receptor (alpha-chain) and gp130 (beta-chain) that gives new insight into the process of molecular recognition and signaling. Based on this model, we predict a fourth binding site on IL-6, a low affinity IL-6-IL-6 interaction, which may be necessary for the sequential assembly of a functional hexameric IL-6 receptor complex.

Disease

Known diseases associated with this structure: Kaposi sarcoma, susceptibility to OMIM:[147620], Osteopenia/osteoporosis OMIM:[147620]

About this Structure

1ALU is a Single protein structure of sequence from Homo sapiens with and as ligands. Full crystallographic information is available from OCA.

Reference

1.9 A crystal structure of interleukin 6: implications for a novel mode of receptor dimerization and signaling., Somers W, Stahl M, Seehra JS, EMBO J. 1997 Mar 3;16(5):989-97. PMID:9118960

Page seeded by OCA on Thu Feb 21 11:45:56 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools